2020 Satellite Symposia Schedule
Tuesday Breakfast, February 11, 2020, 6:15 – 7:15 AM
Gaucher and ASMD. Understanding Differences and Similarities in Disease Mechanisms
Supported by Sanofi Genzyme.
Tuesday Breakfast, February 11, 2020, 6:15 – 7:15 AM
Genetics: Early diagnosis and driving precision medicine in pediatric neurology.
Long-term treatment with Brineura® (cerliponase alfa)
Supported by BioMarin Pharmaceutical, Inc.
Tuesday Lunch, February 11, 2020, 11:45 AM – 12:45 PM
Gaucher disease: Can we build a better roadmap for patient care?
CME Satellite Symposium.
Accredited provider: University of Louisville School of Medicine.
Supported by an educational grant from Takeda.
Tuesday Lunch, February 11, 2020, 11:45 AM – 12:45 PM
Cardiovascular Implications in Fabry Disease:
A multidisciplinary approach to diagnosis, assessment and treatment
CME Satellite Symposium.
Accredited provider: Postgraduate Institute for Medicine.
Supported by an independent educational grant from Amicus Therapeutics Inc.
Tuesday Dinner, February 11, 2020, 6:30 – 8:30 PM
Lysosomal Disorders: Lentiviral gene therapy and the promise of freedom for life
Supported by AVROBIO, Inc.
Tuesday Dinner, February 11, 2020, 6:30 – 8:30 PM
Unveiling ASMD: A closer look into disease diagnosis and burden
Supported by Sanofi Genzyme.
Wednesday Breakfast, February 12, 2020, 6:15 – 7:15 AM
MPS Treatment and Landscape Update
Supported by Ultragenyx Pharmaceutical Inc.
Wednesday Breakfast, February 12, 2020, 6:15 – 7:15 AM
Emerging Developments in the Management of Metachromatic Leukodystrophy
Supported by Orchard Therapeutics.
Wednesday Lunch, February 12, 2020, 11:45 AM – 12:45 PM
Respiratory Involvement in Pompe Disease
Supported by Sanofi Genzyme.
Wednesday Lunch, February 12, 2020, 11:45 AM – 12:45 PM
Fabry Disease: Translating Pharmacogenetics into Clinical Practice
Supported by Amicus Therapeutics Inc.
This satellite is open only to registered attendees from outside the United States. International participants only.
Wednesday Dinner, February 12, 2020, 6:30 – 8:30 PM
Pivotal Trials, Comparative Studies and Clinically Relevant Outcomes in Fabry Disease
Supported by Sanofi Genzyme.
This satellite is open only to registered attendees from outside the United States. International participants only.
Thursday Breakfast, February 13, 2020, 6:15 – 7:15 AM
New Insights on MPS I Genotype-Phenotype Relationships in the Era of Newborn Screening
Supported by Sanofi Genzyme.
Thursday Breakfast, February 13, 2020, 6:15 – 7:15 AM
Fabry Disease Management: 2020 and Beyond
CME Satellite Symposium.
Accredited provider: Postgraduate Institute for Medicine.
Supported by an independent educational grant from Chiesi USA, Inc.
Thursday Lunch, February 13, 2020, 11:45 AM – 12:45 PM
Neurodegenerative Consequences in Lysosomal Diseases: Peripheral, Central and Autonomic
Supported by Takeda.
Thursday Lunch, February 13, 2020, 11:45 AM – 12:45 PM
Fabry in Females: Physician and Patient Insights
Supported by Sanofi Genzyme.
These Satellite Symposia were not part of the official WORLDSymposium™ program, and WORLDSymposium did not approve or endorse any commercial products or services discussed during the Satellite Symposia or offered for sale by any corporate supporter of the Satellite Symposia. These symposia may or may not offer CME credits; these sessions were not approved for CME through WORLDSymposium.
Registration for the 16th Annual Scientific Meeting and an official WORLDSymposium name badge were required to attend any of the satellite symposia.